DiaMedica Therapeutics Inc. (DMAC) Ownership

$7.07

north_east
$0.07 (1%)
Day's range
$6.93
Day's range
$7.13

DiaMedica Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
COOPERMAN LEON G 11/14/2025 3.27 M $17.64 M   98.17% 7.61%
BLACKROCK, INC. 11/12/2025 1.68 M $11.53 M   40.81% 3.91%
MILLENNIUM MANAGEMENT LLC 11/14/2025 1.19 M $8.16 M   100.00% 2.76%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 11/12/2025 875.00 K $6.01 M   34.62% 2.04%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 711.82 K $4.89 M   12.96% 1.66%
VANGUARD GROUP INC 11/07/2025 664.58 K $4.57 M   -56.71% 1.55%
MORGAN STANLEY 11/14/2025 579.59 K $3.98 M   141.02% 1.35%
FIRST MANHATTAN CO. LLC. 11/14/2025 505.00 K $3.47 M   -16.73% 1.18%
STATE STREET CORP 11/14/2025 476.58 K $3.27 M   89.16% 1.11%
BLEICHROEDER LP 11/14/2025 382.32 K $2.63 M   0.00% 0.89%
NORTHERN TRUST CORP 11/14/2025 339.58 K $2.33 M   4.63% 0.79%
LPL FINANCIAL LLC 11/12/2025 203.15 K $1.40 M   2.86% 0.47%
ADVISOR GROUP HOLDINGS, INC. 11/14/2025 182.31 K $1.25 M   26.35% 0.42%
CI PRIVATE WEALTH, LLC 11/14/2025 140.00 K $961.80 K   100.00% 0.33%
CORIENT IA LLC 11/12/2025 132.50 K $910.28 K   100.00% 0.31%
CANTOR FITZGERALD, L. P. 12/01/2025 100.00 K $687.00 K   100.00% 0.23%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 92.43 K $634.97 K   16.18% 0.22%
GOLDMAN SACHS GROUP INC 11/14/2025 77.29 K $531.00 K   331.70% 0.18%
NUVEEN, LLC 11/12/2025 74.67 K $512.96 K   117.39% 0.17%
CITADEL ADVISORS LLC 11/14/2025 69.35 K $476.45 K   100.00% 0.16%
RONALD BLUE TRUST, INC. 10/16/2025 69.12 K $474.87 K   0.00% 0.16%
BANK OF NEW YORK MELLON CORP 11/03/2025 68.94 K $473.62 K   14.78% 0.16%
JANE STREET GROUP, LLC 11/14/2025 57.55 K $395.34 K   100.00% 0.13%
MERIDIAN WEALTH MANAGEMENT, LLC 11/04/2025 51.67 K $354.95 K   89.14% 0.12%
PRIVATE CAPITAL MANAGEMENT, LLC 11/14/2025 50.00 K $343.50 K   100.00% 0.12%
BARCLAYS PLC 11/12/2025 45.44 K $312.17 K   -6.83% 0.11%
ROYAL BANK OF CANADA 11/14/2025 41.93 K $288.00 K   -45.58% 0.10%
QUBE RESEARCH & TECHNOLOGIES LTD 11/14/2025 39.55 K $271.70 K   100.00% 0.09%
MARSHALL WACE, LLP 11/13/2025 39.06 K $268.36 K   -36.71% 0.09%
CREATIVE PLANNING 11/14/2025 38.79 K $266.49 K   100.00% 0.09%
CATALYST FINANCIAL PARTNERS LLC 11/12/2025 38.46 K $264.20 K   0.00% 0.09%
RAYMOND JAMES FINANCIAL INC 11/14/2025 36.50 K $250.76 K   131.50% 0.09%
PENSIONMARK FINANCIAL GROUP, LLC 10/15/2025 34.33 K $235.81 K   7.35% 0.08%
DEUTSCHE BANK AG\ 11/13/2025 32.77 K $225.11 K   100.00% 0.08%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 28.37 K $194.88 K   -13.50% 0.07%
AQR CAPITAL MANAGEMENT LLC 11/14/2025 27.45 K $188.59 K   100.00% 0.06%
RHUMBLINE ADVISERS 11/06/2025 27.36 K $187.94 K   14.49% 0.06%
WELLS FARGO & COMPANY/MN 11/13/2025 21.95 K $150.78 K   49.79% 0.05%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2025 19.66 K $136.00 K   47.07% 0.05%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 19.60 K $134.65 K   100.00% 0.05%
MAN GROUP PLC 11/14/2025 19.41 K $133.37 K   100.00% 0.05%
STONEBRIDGE CAPITAL ADVISORS LLC 11/12/2025 17.50 K $120.23 K   0.00% 0.04%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 16.50 K $113.36 K   100.00% 0.04%
CORNERSTONE WEALTH MANAGEMENT, LLC 11/04/2025 16.25 K $111.64 K   0.00% 0.04%
BANK OF MONTREAL /CAN/ 11/13/2025 15.56 K $106.90 K   0.00% 0.04%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 11/14/2025 14.75 K $101.31 K   2.23% 0.03%
INVESCO LTD. 11/13/2025 14.34 K $98.48 K   3.24% 0.03%
INTECH INVESTMENT MANAGEMENT LLC 11/12/2025 13.94 K $95.73 K   -3.33% 0.03%
UBS GROUP AG 11/13/2025 13.34 K $91.65 K   61.38% 0.03%
JPMORGAN CHASE & CO 11/26/2025 12.79 K $87.83 K   2.42% 0.03%

DiaMedica Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 86 institutional investors and hedge funds held shares of DiaMedica Therapeutics Inc.. The most heavily invested institutionals were:

COOPERMAN LEON G: 3.27 M

BlackRock, Inc.: 1.68 M

MILLENNIUM MANAGEMENT LLC: 1.19 M

PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE: 875,000

GEODE CAPITAL MANAGEMENT, LLC: 711,818

VANGUARD GROUP INC: 664,575

29.69% of DiaMedica Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 13.04 M shares in the last 24 months. This purchase volume represents approximately $92.21 M in transactions.